Related references
Note: Only part of the references are listed.A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases
E. Stoeckle et al.
EJSO (2009)
Can the MRI signal of aggressive fibromatosis be used to predict its behavior?
G. Castellazzi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
Alexander J. F. Lazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Risk factors for development of desmoid tumours in familial adenomatous polyposis
J. H. Lefevre et al.
BRITISH JOURNAL OF SURGERY (2008)
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C. Heinrich et al.
CLINICAL CANCER RESEARCH (2008)
Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis
Marry H. Nieuwenhuis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis
James Church et al.
DISEASES OF THE COLON & RECTUM (2008)
Extra-abdominal primary fibromatosis:: Aggressive management could be avoided in a subgroup of patients
S. Bonvalot et al.
EJSO (2008)
Multimodality treatment of mesenteric desmoid tumours
Monica M. Bertagnolli et al.
EUROPEAN JOURNAL OF CANCER (2008)
DOSE TO NORMAL TISSUES OUTSIDE THE RADIATION THERAPY PATIENT'S TREATED VOLUME: A REVIEW OF DIFFERENT RADIATION THERAPY TECHNIQUES
James A. Purdy
HEALTH PHYSICS (2008)
Long-term outcomes for desmoid tumors treated with radiation therapy
B. Ashleigh Guadagnolo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Multimodality Management of Desmoid Tumors: How Important Is a Negative Surgical Margin?
Marcovalerio Melis et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature
Gabriel Wcislo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients
Juan C. Gutierrez et al.
ANNALS OF SURGERY (2007)
Optimizing treatment of desmoid tumors
Dina Lev et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network
Brigitta G. Baumert et al.
RADIATION ONCOLOGY (2007)
Vinblastine and methotrexate for desmoid fibromatosis in children: Results of a Pediatric Oncology Group phase II trial
Stephen X. Skapek et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibrornatosis
Stefano Signoron et al.
CLINICAL CANCER RESEARCH (2007)
Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
B. Liegl et al.
HISTOPATHOLOGY (2006)
Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis
Anthony Goncalves et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Estrogen receptor-beta expression in extraabdominal fibromatoses - An analysis of 40 cases
AT Deyrup et al.
CANCER (2006)
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis
M Gega et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
TNF-based isolated limb perfusion in unresectable extremity desmoid tumours
DJ Grünhagen et al.
EJSO (2005)
Aggressive fibromatosis
WM Mendenhall et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national patterns of care study
O Micke et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Pediatric aggressive fibromatosis - A retrospective analysis of 13 patients and review of the literature
S Buitendijk et al.
CANCER (2005)
Evaluation of the long term outcome of patients with extremity desmoids
C Chew et al.
EJSO (2004)
Growth factors regulate β-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing
SS Cheon et al.
EXPERIMENTAL CELL RESEARCH (2004)
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
A Hansmann et al.
CANCER (2004)
Chest wall desmoid tumors: Results of surgical intervention
AE Abbas et al.
ANNALS OF THORACIC SURGERY (2004)
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis
Y Kong et al.
CANCER RESEARCH (2004)
Aggressive fibromatosis of the abdominal wall, limbs and limb girdles
SR Phillips et al.
BRITISH JOURNAL OF SURGERY (2004)
Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy
E de Bree et al.
AMERICAN JOURNAL OF SURGERY (2004)
Margins in extra-abdominal desmoid tumors: A comparative analysis
A Leithner et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive. bromatosis (desmoid tumor)
C Tolg et al.
ONCOGENE (2003)
Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution
A Gronchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The pharmacological treatment of aggressive fibromatosis: a systematic review
J Janinis et al.
ANNALS OF ONCOLOGY (2003)
Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis
RM Bright-Thomas et al.
BRITISH JOURNAL OF SURGERY (2002)
Response of extraabdominal desmoid tumors to therapy with imatinib mesylate
J Mace et al.
CANCER (2002)
External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis
RA Zlotecki et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Desmoid tumors: A novel approach for local control
CR Baliski et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
β-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and aggressive fibromatosis and hyperplastic cutaneous wounds
SS Cheon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Treatment of aggressive fibromatosis - A retrospective study of 72 patients followed for 1-27 years
A Sorensen et al.
ACTA ORTHOPAEDICA SCANDINAVICA (2002)
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis
MA Chatzipetrou et al.
SURGERY (2001)
Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)
R Poon et al.
ONCOGENE (2001)
Long-term results with radiation therapy for pediatric desmoid tumors
TE Merchant et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Extraabdominal desmoid tumor
G Pignatti et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2000)
Surgical management of intra-abdominal desmoid tumours
AJ Smith et al.
BRITISH JOURNAL OF SURGERY (2000)
Desmoid disease in patients with familial adenomatous polyposis
C Soravia et al.
DISEASES OF THE COLON & RECTUM (2000)
Share Paper
